Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 42,172 | 26,389 | 257,244 | 211,042 | 326,551 |
| Cost of Goods | 13,814 | 8,727 | 158,992 | 70,083 | 57,591 |
| Gross Profit | 28,358 | 17,662 | 98,252 | 140,959 | 268,960 |
| Operating Expenses | 210,306 | 218,042 | 302,443 | 397,922 | 533,409 |
| Operating Income | -181,134 | -199,653 | -203,199 | -256,880 | -263,858 |
| Interest Expense | 9,001 | 10,734 | 40,542 | 32,474 | 22,959 |
| Other Income | 7,011 | -5,007 | 5,469 | -2,400 | -283 |
| Pre-tax Income | -183,124 | -215,394 | -238,272 | -291,754 | -287,100 |
| Income Tax | 0 | 0 | -380 | N/A | N/A |
| Net Income Continuous | -183,124 | -215,394 | -237,892 | -291,754 | -287,100 |
| Net Income Discontinuous | 351,148 | 243,901 | N/A | N/A | N/A |
| Net Income | $168,024 | $28,507 | $-237,892 | $-291,754 | $-287,100 |
| EPS Basic Total Ops | 1.43 | 0.25 | -2.53 | -3.76 | -3.81 |
| EPS Basic Continuous Ops | -1.56 | -1.88 | -2.53 | -3.76 | -3.81 |
| EPS Basic Discontinuous Ops | 3.00 | 2.13 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.43 | 0.25 | -2.53 | -3.76 | -3.81 |
| EPS Diluted Continuous Ops | -1.56 | -1.88 | -2.53 | -3.76 | -3.81 |
| EPS Diluted Discontinuous Ops | 3.00 | 2.13 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.56 | 0.25 | -2.43 | -3.68 | -3.81 |
| EBITDA(a) | $-177,210 | $-194,377 | $-199,408 | $-253,181 | $-260,404 |